Tysabri's troubles return.
Hoag
Hannah
H
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic / Q000639:trends*; D017277:Drug Approval; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*; D000069442:Natalizumab; D018570:Risk Assessment; D014481:United States
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab